Saturday, July 11, 2026

pharma · Chronic Obstructive Pulmonary Disease · Tuberculosis

Anhui Huaheng Biotechnology

Anhui Huaheng Biotechnology trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Hefei, CN HQ
2005 Founded
32 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Hefei, CN
Founded
2005
Employees
32
Programs
2
Drugs
6
Patents
0
Intelligence · Clinical Trials

Anhui Huaheng Biotechnology clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Anhui Huaheng Biotechnology programs — each row shows trial ID, program name, phase, status, and indication.

Anhui Huaheng Biotechnology trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Anhui Huaheng Biotechnology.

  1. Purified Protein Derivative of BCG(BCG-PPD) — Phase 1

    Clinical update
  2. Hemay005 tablet — Phase 1

    Clinical update

Trial registry

2 studies